Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NEOSTEM: Autologous Cord Blood Stem Cells for Neonatal HIE
NCT02881970Phase 2Recruiting
- Sponsor
- Assistance Publique-Hôpitaux de Marseille
- Start
- Feb 2020
- Primary completion
- Apr 2028
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of autologous cord blood mononuclear cells in hypoxic-ischemic encephalopathy (HIE), sponsored by Assistance Publique-Hôpitaux de Marseille. Started Feb 2020; status: recruiting.
02
Drugs
autologous cord blood mononuclear cells
03
Conditions
hypoxic-ischemic encephalopathy (HIE)
Beyond the preview
Go deeper on NCT02881970.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02881970.